Drug Discovery Services Market
Drug Discovery Services Market Analysis by Process (Target Selection, Target Validation, Hit-To-Lead Identification), by Type (Medicinal Chemistry, Biology Services, Pharmacokinetics), by Drug Type (Small Molecules and Biologics) by Therapeutic Area, by Region - Global Market Insights 2022-2032
Analysis of Drug Discovery Services market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Drug Discovery Services Market Outlook (2022-2032)
The drug discovery services market is forecasted to reach US$ 50 Billion by 2032, up from US$ 19 Billion in 2022, at a CAGR of 10.1%.
A Y-o-Y growth rate of nearly 12% is expected for the market in 2022. As of 2021, the market was valued at US$ 17 Billion.
Report Attributes |
Details |
|
Anticipated Base Year Value (2021) |
US$ 17 Billion |
|
Expected Market Value (2022) |
US$ 19 Billion |
|
Projected Forecast Value (2032) |
US$ 50 Billion |
|
Global Growth Rate (2022-2032) |
10.1% CAGR |
|
Growth Rate of the U.S (2022-2032) |
9.8% CAGR |
|
Expected Market Value of China (2032) |
US$ 15 Billion |
|
Key Drug Discovery Services Service Providers |
|
Growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, rising demand for outsourcing analytical testing services, initiatives for research on rare diseases and orphan drugs, and the high cost of in-house drug development are all creating new revenue pockets in the drug discovery services market.
Furthermore, factors such as rising R&D expenditure in the pharmaceutical and biopharmaceutical industries, rising initiatives for research on rare diseases and orphan drugs, a rapidly growing focus on drug discovery and a proliferating pharmaceutical industry are all expected to influence market growth in the future.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Drug Discovery Services Market Revenue Analysis 2015-2021 vs. Future Outlook 2022-2032
According to Fact.MR, the global market for drug discovery services is expected to increase rapidly. The global market for drug discovery services is expected to generate US$ 50 Billion in sales by the end of 2032. Advances in drug discovery technology are resulting in improved drug discovery services.
Some of the market's forthcoming trends in drug discovery technology include regulatory initiatives toward Pharmacogenomic technology, combinatorial chemistry technology, and so on. There has also been a rise in the use of label-free methods. Increased R&D efforts and spending, as well as pharmaceutical businesses shifting to outsourcing, are some of the causes driving the expansion of drug discovery services.
The use of improved technologies in the drug development process is also a key driver of market expansion. However, severe rules in certain jurisdictions on drug discovery services, high costs associated with drug research and development, and the use of animals in testing are stifling industry growth.
Prominent Drug Discovery Services Industry Growth Drivers
Increasing R&D Spending in Pharmaceutical and Biopharma Businesses
Most pharmaceutical, biopharmaceutical, and medical device businesses make significant investments in the development of new medications and technologies. The pharmaceutical sector is heavily invested in R&D. Pharmaceutical firms spend in R&D in order to bring high-quality, innovative medicines to market.
According to trends, the leading pharma firms are enhancing their R&D efficiency through large R&D investments to realize long-term benefits and joint R&D efforts. According to the EvaluatePharma analysis, global pharmaceutical R&D investment was valued at US$ 137 billion in 2012, and is expected to climb to US$ 198 billion by 2020. As a result of the COVID-19 pandemic, the worldwide pharmaceutical R&D growth rate is expected to fall to 0.1% in 2020. According to the analysis, R&D spending is predicted to expand gradually at a CAGR of 4.2% between 2020 and 2026 to reach USD 254.0 billion, slower than the historical CAGR of 4.7% between 2012 and 2020.
Pharmaceutical and biopharmaceutical businesses' increasing R&D expenditures are leading them to seek fully integrated or functional outsourcing services for drug research and development, from the early development stage through the late-stage development phase. Outsourcing has grown as a strategic solution to offset the shortage of in-house resources necessary for new product development as pharma businesses face great pressure to limit fixed costs. Large pharmaceutical corporations are shifting to a leaner business strategy that mainly depends on outsourcing.
Most pharmaceutical and biopharmaceutical businesses outsource their testing services throughout R&D to increase profitability, meet drug development timeframes, and save money. This is evidenced by recent collaborations between large pharmaceutical corporations and contract research organizations (CROs) that provide drug discovery and development services.
As a result, rising pharmaceutical R&D spending fuels the development of the drug discovery services industry.
Constant Research to find a Cure for COVID-19 widened Expansion Prospects
The COVID-19 pandemic provided a massive boost to the pharmaceutical industry, in terms of the number of medications authorized by the US FDA. This year saw the approval of 53 medications, which was only topped in 2018 with 59 pharmaceutical agents.
In 2020, there were 53 approvals totaling 40 novel chemical entities and 13 biologics (of which ten were monoclonal antibodies, two were antibody-drug conjugates, and three were peptides, and two, oligonucleotides). In the previous three years (2018–2020), the FDA approved 160 medications, compared to only 21 in 2010.
This increase in the number of authorized drugs globally can be linked to increased biopharmaceutical company spending in the development of biologics and biosimilars. Biologics, such as proteins, peptides, and monoclonal antibodies, account for more than half of the therapeutic candidates in the discovery stage. In 2022, biologics are predicted to account for about half of the revenue earned by the top 100 pharmaceutical product sales.
Despite the fact that small-molecule pharmaceuticals dominate the global pharmaceutical industry, the share of biologics, biosimilars, and large-molecule medications is increasing, owing to the introduction of new biologic-based treatments and rising earnings from current biologics.
At each level, biologics and biosimilars need more specialized testing services than small molecules. The growing demand for these services to be outsourced to CROs is likely to boost the demand of the drug discovery services market in the coming years.
Key Challenges Prevalent in the Global Drug Discovery Services Market
Strict Guidelines Control Drug Development and Animal Testing
Regulatory agencies' primary priority during medication approval is ensuring safety and efficacy. Although these procedures serve to assure the quality of medicines that are released to the market, they significantly raise the cost of medication research and the final product. This aspect can have a major influence on medicine adoption in price-sensitive emerging economies. Aside from that, different legislations that protect product quality (such as GMP) sometimes raise production prices.
Animals are used in drug development under strict limits. Mice, rats, fish, amphibians, and reptiles are the most common animals utilized in research. Concerns over the ethical use of animals in research have prompted countries to enact animal safety and usage regulations, which pose a number of hurdles to the smooth operation of drug discovery research.
Companies have been obliged to find other methods to reduce animal use as a result of this. Novo Nordisk, for example, employs biosimulation, which entails employing computer models to imitate human biology. However, this has not been fully implemented throughout the sector.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Analysis
What is the Growth Outlook for Drug Discovery Services in the U.S?
United States to lead the Drug Discovery Services Market
In terms of pharmaceutical R&D investment, United States leads the globe. It is also the most important market for both bulk pharmaceuticals and final dosage formulations. The market works as a free economy, with the goal of implementing transparent trading processes and restricting anti-competitive behavior.
Over the projection period, a significant push for generic pharmaceuticals and biosimilars is likely to enhance demand for specialty and complex ingredients. For example, Bayer entered into a partnership arrangement with the artificial intelligence drug discovery services business Exscientia in January 2020 to develop and optimize innovative lead structures for prospective therapeutic candidates in the treatment of cardiovascular and Oncological disorders. Because biologics are more expensive, the country has a lot of prospects for biosimilars.
The COVID-19 pandemic underlined the importance of North American corporations and research groups collaborating with the government to create new medications to address future health catastrophes. Several universities and significant businesses are engaged on creating corona virus vaccines. For example, Eli Lilly collaborated with AbCellera to create vaccinations.
How do Growth Prospects appear in the Chinese Market?
Rising Demand for Drug Discovery Informatics is Attributable to the Expanding Population Base and Growth in the Prevalence of Infectious Illnesses. Because of the vast number of skilled researchers and low-cost operations in rising nation such as China, Asia-Pacific is predicted to increase at a high rate from 2022 to 2032. Emerging as the pinnacle of the global telecommunications and digital China is a valuable market.
During the forecast period, the drug discovery services market in the area is expected to increase at a quick pace. An increase in government efforts is expected to strengthen China’s market share. Increased need for drug discovery informatics in China is ascribed to a huge population base and an increase in the prevalence of infectious illnesses. In the next years, China is expected to provide considerable prospects to the drug discovery services industry.
Country-wise Forecast CAGRs in the Drug Discovery Services Market
Country wise Analysis |
Growth Rate |
|---|---|
|
U.S |
9.8% |
|
U.K |
9% |
|
China |
9.7% |
|
Japan |
8.5% |
|
South Korea |
7.6% |
Category-wise Insights
Why Medicinal Chemistry is the Most Preferred Type?
Medicinal Chemistry will be the Most Common Type of Drug Discovery Service
Medicinal chemistry is expected to be the most popular service type in the drug discovery services industry. Medicinal chemistry is expected to generate about US$ 6 Billion in revenue.
Outsourcing by pharmaceutical companies has increased, and this is emerging as a driving element. Many Asian drug discovery service companies are expanding their presence in North America and Europe.
Why is Demand for Small Molecules Rising Rapidly?
Small Molecules to Experience the Most Revenue Growth
Small molecules are expected to account for the greatest share of revenue when compared to biologics. Small molecules are expected to generate more than US$ 10.8 Billion in revenue by the end of 2032.
Small molecules are gaining popularity because they are simple, easy to describe, and well defined. Small chemicals can also readily infiltrate cells and kill cancer cells.
Which Therapeutic Area will Leverage Drug Discovery Services the Most?
Oncology will have the Highest Revenue Share in the Therapeutic Area
Oncology is expected to be the greatest therapeutic area during the projection period. Oncology is expected to generate more than US$ 6.9 Billion in revenue by the end of 2032.
The growing number of cancer patients has resulted in a strong need for cancer medicines. As a result, oncology is expected to develop significantly in the next years.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
The global market for Drug Discovery Services is extremely fragmented, with several large firms.
- Eurofins Discovery and PharmaResouces announced cooperation in February 2020 to construct a combined drug discovery platform to accelerate the development of small-molecule pharmaceuticals.
Key Segments Covered in the Drug Discovery Services Industry Report
-
By Process :
- Target Selection
- Target Validation
- Hit-To-Lead Identification
- Lead Optimization
- Candidate Validation
-
By Type :
- Medicinal Chemistry
- Biology Services
- Drug Metabolism and Pharmacokinetics
-
By Drug Type :
- Small Molecules
- Biologics
-
By Therapeutic Area :
- Oncology
- Neurology
- Cardiovascular Diseases
- Respiratory Diseases
- Diabetes and Other Therapeutic Areas
-
By Region :
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Table of Content
1. Global Economic Outlook 2. Global Drug Discovery Services Market - Executive Summary 3. Global Drug Discovery Services Market Overview 3.1. Introduction 3.1.1. Global Drug Discovery Services Market Taxonomy 3.1.2. Global Drug Discovery Services Market Definition 3.2. Global Drug Discovery Services Market Size (US$ Mn) and Forecast, 2015-2032 3.2.1. Global Drug Discovery Services Market Y-o-Y Growth 3.3. Global Drug Discovery Services Market Dynamics 3.4. Supply Chain 3.5. Cost Structure 3.6. PESTL Analysis 3.7. Product Life Cycle Analysis 3.8. Drug Discovery & Development Process 3.9. Roadmap to Optimize Regulatory and Commercial Success 3.10. Evolution of R&D Drug Discovery Outsourcing 3.11. Service Provider List 3.12. Key Participants Market Presence (Intensity Map) By Region 4. Global Drug Discovery Services Market Analysis and Forecast 2015-2032 4.1. Global Drug Discovery Services Market Size and Forecast by Process, 2015-2032 4.1.1. Target Selection Market Size and Forecast, 2015-2032 4.1.1.1. Revenue (US$ Mn) Comparison, By Region 4.1.1.2. Market Share Comparison, By Region 4.1.1.3. Y-o-Y growth Comparison, By Region 4.1.2. Target Validation Market Size and Forecast, 2015-2032 4.1.2.1. Revenue (US$ Mn) Comparison, By Region 4.1.2.2. Market Share Comparison, By Region 4.1.2.3. Y-o-Y growth Comparison, By Region 4.1.3. Hit-To-Lead Identification Market Size and Forecast, 2015-2032 4.1.3.1. Revenue (US$ Mn) Comparison, By Region 4.1.3.2. Market Share Comparison, By Region 4.1.3.3. Y-o-Y growth Comparison, By Region 4.1.4. Lead Optimization Market Size and Forecast, 2015-2032 4.1.4.1. Revenue (US$ Mn) Comparison, By Region 4.1.4.2. Market Share Comparison, By Region 4.1.4.3. Y-o-Y growth Comparison, By Region 4.1.5. Candidate Validation Market Size and Forecast, 2015-2032 4.1.5.1. Revenue (US$ Mn) Comparison, By Region 4.1.5.2. Market Share Comparison, By Region 4.1.5.3. Y-o-Y growth Comparison, By Region 4.2. Global Drug Discovery Services Market Size and Forecast By Type, 2015-2032 4.2.1. Medicinal Chemistry Market Size and Forecast, 2015-2032 4.2.1.1. Revenue (US$ Mn) Comparison, By Region 4.2.1.2. Market Share Comparison, By Region 4.2.1.3. Y-o-Y growth Comparison, By Region 4.2.2. Biology Services Market Size and Forecast, 2015-2032 4.2.2.1. Revenue (US$ Mn) Comparison, By Region 4.2.2.2. Market Share Comparison, By Region 4.2.2.3. Y-o-Y growth Comparison, By Region 4.2.3. Drug Metabolism and Pharmacokinetics Market Size and Forecast, 2015-2032 4.2.3.1. Revenue (US$ Mn) Comparison, By Region 4.2.3.2. Market Share Comparison, By Region 4.2.3.3. Y-o-Y growth Comparison, By Region 4.3. Global Drug Discovery Services Market Size and Forecast By Drug Type, 2015-2032 4.3.1. Small Molecules Market Size and Forecast, 2015-2032 4.3.1.1. Revenue (US$ Mn) Comparison, By Region 4.3.1.2. Market Share Comparison, By Region 4.3.1.3. Y-o-Y growth Comparison, By Region 4.3.2. Biologics Market Size and Forecast, 2015-2032 4.3.2.1. Revenue (US$ Mn) Comparison, By Region 4.3.2.2. Market Share Comparison, By Region 4.3.2.3. Y-o-Y growth Comparison, By Region 4.4. Global Drug Discovery Services Market Size and Forecast By Therapeutic Area, 2015-2032 4.4.1. Oncology Market Size and Forecast, 2015-2032 4.4.1.1. Revenue (US$ Mn) Comparison, By Region 4.4.1.2. Market Share Comparison, By Region 4.4.1.3. Y-o-Y growth Comparison, By Region 4.4.2. Neurology Market Size and Forecast, 2015-2032 4.4.2.1. Revenue (US$ Mn) Comparison, By Region 4.4.2.2. Market Share Comparison, By Region 4.4.2.3. Y-o-Y growth Comparison, By Region 4.4.3. Respiratory Diseases Market Size and Forecast, 2015-2032 4.4.3.1. Revenue (US$ Mn) Comparison, By Region 4.4.3.2. Market Share Comparison, By Region 4.4.3.3. Y-o-Y growth Comparison, By Region 4.4.4. Respiratory Diseases Market Size and Forecast, 2015-2032 4.4.4.1. Revenue (US$ Mn) Comparison, By Region 4.4.4.2. Market Share Comparison, By Region 4.4.4.3. Y-o-Y growth Comparison, By Region 4.4.5. Diabetes Market Size and Forecast, 2015-2032 4.4.5.1. Revenue (US$ Mn) Comparison, By Region 4.4.5.2. Market Share Comparison, By Region 4.4.5.3. Y-o-Y growth Comparison, By Region 4.4.6. Other Therapeutic Areas Market Size and Forecast, 2015-2032 4.4.6.1. Revenue (US$ Mn) Comparison, By Region 4.4.6.2. Market Share Comparison, By Region 4.4.6.3. Y-o-Y growth Comparison, By Region 5. North America Drug Discovery Services Market Size and Forecast, 2015-2032 5.1. North America Outlook 5.2. North America Parent Market Outlook 5.3. North America Target Market Outlook 5.4. Revenue (US$ Mn) Comparison, By Country 5.4.1. US Market Size and Forecast (US$ Mn), 2015-2032 5.4.2. Canada Market Size and Forecast (US$ Mn), 2015-2032 5.5. Revenue (US$ Mn) Comparison, By Process 5.6. Revenue (US$ Mn) Comparison, By Type 5.7. Revenue (US$ Mn) Comparison, By Drug Type 5.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 6. Latin America Drug Discovery Services Market Size and Forecast, 2015-2032 6.1. Latin America Outlook 6.2. Latin America Parent Market Outlook 6.3. Latin America Target Market Outlook 6.4. Revenue (US$ Mn) Comparison, By Country 6.4.1. Brazil Market Size and Forecast (US$ Mn), 2015-2032 6.4.2. Mexico Market Size and Forecast (US$ Mn), 2015-2032 6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2015-2032 6.5. Revenue (US$ Mn) Comparison, By Process 6.6. Revenue (US$ Mn) Comparison, By Type 6.7. Revenue (US$ Mn) Comparison, By Drug Type 6.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 7. Europe Drug Discovery Services Market Size and Forecast, 2015-2032 7.1. Europe Outlook 7.2. Europe Parent Market Outlook 7.3. Europe Target Market Outlook 7.4. Revenue (US$ Mn) Comparison, By Country 7.4.1. Germany Market Size and Forecast (US$ Mn), 2015-2032 7.4.2. UK Market Size and Forecast (US$ Mn), 2015-2032 7.4.3. France Market Size and Forecast (US$ Mn), 2015-2032 7.4.4. Spain Market Size and Forecast (US$ Mn), 2015-2032 7.4.5. Italy Market Size and Forecast (US$ Mn), 2015-2032 7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2015-2032 7.5. Revenue (US$ Mn) Comparison, By Process 7.6. Revenue (US$ Mn) Comparison, By Type 7.7. Revenue (US$ Mn) Comparison, By Drug Type 7.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 8. Japan Drug Discovery Services Market Size and Forecast, 2015-2032 8.1. Japan Outlook 8.2. Japan Parent Market Outlook 8.3. Japan Target Market Outlook 8.4. Revenue (US$ Mn) Comparison, By Country 8.4.1. Japan Market Size and Forecast (US$ Mn), 2015-2032 8.5. Revenue (US$ Mn) Comparison, By Process 8.6. Revenue (US$ Mn) Comparison, By Type 8.7. Revenue (US$ Mn) Comparison, By Drug Type 8.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 9. APEJ Drug Discovery Services Market Size and Forecast, 2015-2032 9.1. APEJ Outlook 9.2. APEJ Parent Market Outlook 9.3. APEJ Target Market Outlook 9.4. Revenue (US$ Mn) Comparison, By Country 9.4.1. China Market Size and Forecast (US$ Mn), 2015-2032 9.4.2. India Market Size and Forecast (US$ Mn), 2015-2032 9.4.3. Thailand Market Size and Forecast (US$ Mn), 2015-2032 9.4.4. Singapore Market Size and Forecast (US$ Mn), 2015-2032 9.4.5. Australia Market Size and Forecast (US$ Mn), 2015-2032 9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2015-2032 9.5. Revenue (US$ Mn) Comparison, By Process 9.6. Revenue (US$ Mn) Comparison, By Type 9.7. Revenue (US$ Mn) Comparison, By Drug Type 9.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 10. MEA Drug Discovery Services Market Size and Forecast, 2015-2032 10.1. MEA Outlook 10.2. MEA Parent Market Outlook 10.3. MEA Target Market Outlook 10.4. Revenue (US$ Mn) Comparison, By Country 10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2015-2032 10.4.2. South Africa Market Size and Forecast (US$ Mn), 2015-2032 10.4.3. Israel Market Size and Forecast (US$ Mn), 2015-2032 10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2015-2032 10.5. Revenue (US$ Mn) Comparison, By Process 10.6. Revenue (US$ Mn) Comparison, By Type 10.7. Revenue (US$ Mn) Comparison, By Drug Type 10.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 11. Global Drug Discovery Services Market Company Share, Competition Landscape and Company Profiles 11.1. Company Share Analysis 11.2. Competition Landscape 11.3. Company Profiles 11.3.1. Thermo Fisher Scientific, Inc. 11.3.2. GE Healthcare 11.3.3. Charles River Laboratories International 11.3.4. Agilent Technologies, Inc. 11.3.5. Eli Lilly and Company 11.3.6. Lonza Group Ltd 11.3.7. WuXi AppTec Co. Ltd. 11.3.8. Evotec AG 11.3.9. Pharmaceutical Product Development LLC 11.3.10. Merck Millipore 11.3.11. Albany Molecular Research, Inc. 11.3.12. Covance Inc. 11.3.13. Genscript Biotech Corporation 11.3.14. Aurigene Discovery Technologies Limited 11.3.15. Syngene International Limited 11.3.16. Promega Corporation 11.3.17. SRI International, Inc. 11.3.18. Chembridge Corporation 11.3.19. GVK Biosciences Private Limited 11.3.20. Domainex Ltd. 11.3.21. Selcia Limited 11.3.22. Viva Biotech Ltd. 11.3.23. Jubilant Biosys Limited 11.3.24. Ubiquigent Limited 11.3.25. ReproCELL, Inc. 11.3.26. DiscoverX Corporation 11.3.27. Creative Bioarray 11.4. Key Takeaways 12. Research Methodology 13. Secondary and Primary Sources 14. Assumptions and Acronyms 15. Disclaimer
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
TABLE 1 Global Drug Discovery Services Market Value (US$ Mn), 2015-2021
TABLE 2 Global Drug Discovery Services Market Value (US$ Mn), 2022-2032
TABLE 3 Global Drug Discovery Services Market Value (US$ Mn) and Y-o-Y, 2022-2032
TABLE 4 Global Target Selection Segment Value (US$ Mn), By Region 2015-2021
TABLE 5 Global Target Selection Segment Value (US$ Mn), By Region 2022-2032
TABLE 6 Global Target Selection Segment Market Share, By Region 2015-2021
TABLE 7 Global Target Selection Segment Market Share, By Region 2022-2032
TABLE 8 Global Target Selection Segment Y-o-Y, By Region 2022-2032
TABLE 9 Global Target Validation Segment Value (US$ Mn), By Region 2015-2021
TABLE 10 Global Target Validation Segment Value (US$ Mn), By Region 2022-2032
TABLE 11 Global Target Validation Segment Market Share, By Region 2015-2021
TABLE 12 Global Target Validation Segment Market Share, By Region 2022-2032
TABLE 13 Global Target Validation Segment Y-o-Y, By Region 2022-2032
TABLE 14 Global Hit-To-Lead Identification Segment Value (US$ Mn), By Region 2015-2021
TABLE 15 Global Hit-To-Lead Identification Segment Value (US$ Mn), By Region 2022-2032
TABLE 16 Global Hit-To-Lead Identification Segment Market Share, By Region 2015-2021
TABLE 17 Global Hit-To-Lead Identification Segment Market Share, By Region 2022-2032
TABLE 18 Global Hit-To-Lead Identification Segment Y-o-Y, By Region 2022-2032
TABLE 19 Global Lead Optimization Segment Value (US$ Mn), By Region 2015-2021
TABLE 20 Global Lead Optimization Segment Value (US$ Mn), By Region 2022-2032
TABLE 21 Global Lead Optimization Segment Market Share, By Region 2015-2021
TABLE 22 Global Lead Optimization Segment Market Share, By Region 2022-2032
TABLE 23 Global Lead Optimization Segment Y-o-Y, By Region 2022-2032
TABLE 24 Global Candidate Validation Segment Value (US$ Mn), By Region 2015-2021
TABLE 25 Global Candidate Validation Segment Value (US$ Mn), By Region 2022-2032
TABLE 26 Global Candidate Validation Segment Market Share, By Region 2015-2021
TABLE 27 Global Candidate Validation Segment Market Share, By Region 2022-2032
TABLE 28 Global Candidate Validation Segment Y-o-Y, By Region 2022-2032
TABLE 29 Global Medicinal Chemistry Segment Value (US$ Mn), By Region 2015-2021
TABLE 30 Global Medicinal Chemistry Segment Value (US$ Mn), By Region 2022-2032
TABLE 31 Global Medicinal Chemistry Segment Market Share, By Region 2015-2021
TABLE 32 Global Medicinal Chemistry Segment Market Share, By Region 2022-2032
TABLE 33 Global Medicinal Chemistry Segment Y-o-Y, By Region 2022-2032
TABLE 34 Global Biology Services Segment Value (US$ Mn), By Region 2015-2021
TABLE 35 Global Biology Services Segment Value (US$ Mn), By Region 2022-2032
TABLE 36 Global Biology Services Segment Market Share, By Region 2015-2021
TABLE 37 Global Biology Services Segment Market Share, By Region 2022-2032
TABLE 38 Global Biology Services Segment Y-o-Y, By Region 2022-2032
TABLE 39 Global Drug Metabolism and Pharmacokinetics Segment Value (US$ Mn), By Region 2015-2021
TABLE 40 Global Drug Metabolism and Pharmacokinetics Segment Value (US$ Mn), By Region 2022-2032
TABLE 41 Global Drug Metabolism and Pharmacokinetics Segment Market Share, By Region 2015-2021
TABLE 42 Global Drug Metabolism and Pharmacokinetics Segment Market Share, By Region 2022-2032
TABLE 43 Global Drug Metabolism and Pharmacokinetics Segment Y-o-Y, By Region 2022-2032
TABLE 44 Global Small Molecules Segment Value (US$ Mn), By Region 2015-2021
TABLE 45 Global Small Molecules Segment Value (US$ Mn), By Region 2022-2032
TABLE 46 Global Small Molecules Segment Market Share, By Region 2015-2021
TABLE 47 Global Small Molecules Segment Market Share, By Region 2022-2032
TABLE 48 Global Small Molecules Segment Y-o-Y, By Region 2022-2032
TABLE 49 Global Biologics Segment Value (US$ Mn), By Region 2015-2021
TABLE 50 Global Biologics Segment Value (US$ Mn), By Region 2022-2032
TABLE 51 Global Biologics Segment Market Share, By Region 2015-2021
TABLE 52 Global Biologics Segment Market Share, By Region 2022-2032
TABLE 53 Global Biologics Segment Y-o-Y, By Region 2022-2032
TABLE 54 Global Oncology Segment Value (US$ Mn), By Region 2015-2021
TABLE 55 Global Oncology Segment Value (US$ Mn), By Region 2022-2032
TABLE 56 Global Oncology Segment Market Share, By Region 2015-2021
TABLE 57 Global Oncology Segment Market Share, By Region 2022-2032
TABLE 58 Global Oncology Segment Y-o-Y, By Region 2022-2032
TABLE 59 Global Neurology Segment Value (US$ Mn), By Region 2015-2021
TABLE 60 Global Neurology Segment Value (US$ Mn), By Region 2022-2032
TABLE 61 Global Neurology Segment Market Share, By Region 2015-2021
TABLE 62 Global Neurology Segment Market Share, By Region 2022-2032
TABLE 63 Global Neurology Segment Y-o-Y, By Region 2022-2032
TABLE 64 Global Cardiovascular Diseases Segment Value (US$ Mn), By Region 2015-2021
TABLE 65 Global Cardiovascular Diseases Segment Value (US$ Mn), By Region 2022-2032
TABLE 66 Global Cardiovascular Diseases Segment Market Share, By Region 2015-2021
TABLE 67 Global Cardiovascular Diseases Segment Market Share, By Region 2022-2032
TABLE 68 Global Cardiovascular Diseases Segment Y-o-Y, By Region 2022-2032
TABLE 69 Global Respiratory Diseases Segment Value (US$ Mn), By Region 2015-2021
TABLE 70 Global Respiratory Diseases Segment Value (US$ Mn), By Region 2022-2032
TABLE 71 Global Respiratory Diseases Segment Market Share, By Region 2015-2021
TABLE 72 Global Respiratory Diseases Segment Market Share, By Region 2022-2032
TABLE 73 Global Respiratory Diseases Segment Y-o-Y, By Region 2022-2032
TABLE 74 Global Diabetes Segment Value (US$ Mn), By Region 2015-2021
TABLE 75 Global Diabetes Segment Value (US$ Mn), By Region 2022-2032
TABLE 76 Global Diabetes Segment Market Share, By Region 2015-2021
TABLE 77 Global Diabetes Segment Market Share, By Region 2022-2032
TABLE 78 Global Diabetes Segment Y-o-Y, By Region 2022-2032
TABLE 79 Global Other Therapeutic Areas Segment Value (US$ Mn), By Region 2015-2021
TABLE 80 Global Other Therapeutic Areas Segment Value (US$ Mn), By Region 2022-2032
TABLE 81 Global Other Therapeutic Areas Segment Market Share, By Region 2015-2021
TABLE 82 Global Other Therapeutic Areas Segment Market Share, By Region 2022-2032
TABLE 83 Global Other Therapeutic Areas Segment Y-o-Y, By Region 2022-2032
TABLE 84 North America Current Expenditure on Health, (% of GDP), by Country, 2022-2032
TABLE 85 North America Per Capita Health Expenditure (US$ PPP), by Country, 2022-2032
TABLE 86 North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022-2032
TABLE 87 North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022-2032
TABLE 88 North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022-2032
TABLE 89 North America Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
TABLE 90 North America Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
TABLE 91 North America Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
TABLE 92 North America Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
TABLE 93 North America Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
TABLE 94 North America Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
TABLE 95 North America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
TABLE 96 North America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
TABLE 97 North America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
TABLE 98 North America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
TABLE 99 Latin America Current Expenditure on Health, (% of GDP), by Country, 2022-2032
TABLE 100 Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2022-2032
TABLE 101 Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022-2032
TABLE 102 Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022-2032
TABLE 103 Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022-2032
TABLE 104 Latin America Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
TABLE 105 Latin America Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
TABLE 106 Latin America Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
TABLE 107 Latin America Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
TABLE 108 Latin America Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
TABLE 109 Latin America Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
TABLE 110 Latin America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
TABLE 111 Latin America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
TABLE 112 Latin America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
TABLE 113 Latin America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
TABLE 114 Europe Current Expenditure on Health, (% of GDP), by Country, 2022-2032
TABLE 115 Europe Per Capita Health Expenditure (US$ PPP), by Country, 2022-2032
TABLE 116 Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022-2032
TABLE 117 Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022-2032
TABLE 118 Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022-2032
TABLE 119 Europe Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
TABLE 120 Europe Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
TABLE 121 Europe Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
TABLE 122 Europe Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
TABLE 123 Europe Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
TABLE 124 Europe Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
TABLE 125 Europe Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
TABLE 126 Europe Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
TABLE 127 Europe Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
TABLE 128 Europe Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
TABLE 129 Japan Current Expenditure on Health, (% of GDP), by Country, 2022-2032
TABLE 130 Japan Per Capita Health Expenditure (US$ PPP), by Country, 2022-2032
TABLE 131 Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022-2032
TABLE 132 Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022-2032
TABLE 133 Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022-2032
TABLE 134 Japan Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
TABLE 135 Japan Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
TABLE 136 Japan Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
TABLE 137 Japan Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
TABLE 138 Japan Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
TABLE 139 Japan Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
TABLE 140 Japan Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
TABLE 141 Japan Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
TABLE 142 Japan Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
TABLE 143 Japan Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
TABLE 144 APEJ Current Expenditure on Health, (% of GDP), by Country, 2022-2032
TABLE 145 APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2022-2032
TABLE 146 APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022-2032
TABLE 147 APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022-2032
TABLE 148 APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022-2032
TABLE 149 APEJ Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
TABLE 150 APEJ Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
TABLE 151 APEJ Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
TABLE 152 APEJ Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
TABLE 153 APEJ Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
TABLE 154 APEJ Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
TABLE 155 APEJ Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
TABLE 156 APEJ Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
TABLE 157 APEJ Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
TABLE 158 APEJ Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
TABLE 159 MEA Current Expenditure on Health, (% of GDP), by Country, 2022-2032
TABLE 160 MEA Per Capita Health Expenditure (US$ PPP), by Country, 2022-2032
TABLE 161 MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022-2032
TABLE 162 MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022-2032
TABLE 163 MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022-2032
TABLE 164 MEA Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
TABLE 165 MEA Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
TABLE 166 MEA Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
TABLE 167 MEA Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
TABLE 168 MEA Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
TABLE 169 MEA Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
TABLE 170 MEA Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
TABLE 171 MEA Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
TABLE 172 MEA Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
TABLE 173 MEA Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
FIG. 1 Global Drug Discovery Services Market Value (US$ Mn), 2015-2021
FIG. 2 Global Drug Discovery Services Market Value (US$ Mn) Forecast, 2022-2032
FIG. 3 Global Drug Discovery Services Market Value (US$ Mn) and Y-o-Y, 2022-2032
FIG. 4 Global Target Selection Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 5 Global Target Selection Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 6 Global Target Selection Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 7 Global Target Validation Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 8 Global Target Validation Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 9 Global Target Validation Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 10 Global Hit-To-Lead Identification Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 11 Global Hit-To-Lead Identification Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 12 Global Hit-To-Lead Identification Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 13 Global Lead Optimization Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 14 Global Lead Optimization Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 15 Global Lead Optimization Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 16 Global Candidate Validation Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 17 Global Candidate Validation Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 18 Global Candidate Validation Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 19 Global Medicinal Chemistry Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 20 Global Medicinal Chemistry Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 21 Global Medicinal Chemistry Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 22 Global Biology Services Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 23 Global Biology Services Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 24 Global Biology Services Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 25 Global Drug Metabolism and Pharmacokinetics Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 26 Global Drug Metabolism and Pharmacokinetics Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 27 Global Drug Metabolism and Pharmacokinetics Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 28 Global Small Molecules Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 29 Global Small Molecules Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 30 Global Small Molecules Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 31 Global Biologics Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 32 Global Biologics Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 33 Global Biologics Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 34 Global Oncology Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 35 Global Oncology Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 36 Global Oncology Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 37 Global Neurology Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 38 Global Neurology Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 39 Global Neurology Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 40 Global Cardiovascular Diseases Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 41 Global Cardiovascular Diseases Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 42 Global Cardiovascular Diseases Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 43 Global Respiratory Diseases Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 44 Global Respiratory Diseases Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 45 Global Respiratory Diseases Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 46 Global Diabetes Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 47 Global Diabetes Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 48 Global Diabetes Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 49 Global Other Therapeutic Areas Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 50 Global Other Therapeutic Areas Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 51 Global Other Therapeutic Areas Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 52 North America Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
FIG. 53 North America Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
FIG. 54 North America Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
FIG. 55 North America Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
FIG. 56 North America Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
FIG. 57 North America Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
FIG. 58 North America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
FIG. 59 North America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
FIG. 60 North America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
FIG. 61 North America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
FIG. 62 Latin America Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
FIG. 63 Latin America Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
FIG. 64 Latin America Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
FIG. 65 Latin America Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
FIG. 66 Latin America Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
FIG. 67 Latin America Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
FIG. 68 Latin America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
FIG. 69 Latin America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
FIG. 70 Latin America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
FIG. 71 Latin America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
FIG. 72 Europe Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
FIG. 73 Europe Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
FIG. 74 Europe Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
FIG. 75 Europe Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
FIG. 76 Europe Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
FIG. 77 Europe Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
FIG. 78 Europe Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
FIG. 79 Europe Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
FIG. 80 Europe Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
FIG. 81 Europe Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
FIG. 82 Japan Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
FIG. 83 Japan Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
FIG. 84 Japan Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
FIG. 85 Japan Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
FIG. 86 Japan Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
FIG. 87 Japan Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
FIG. 88 Japan Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
FIG. 89 Japan Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
FIG. 90 Japan Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
FIG. 91 Japan Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
FIG. 92 APEJ Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
FIG. 93 APEJ Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
FIG. 94 APEJ Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
FIG. 95 APEJ Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
FIG. 96 APEJ Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
FIG. 97 APEJ Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
FIG. 98 APEJ Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
FIG. 99 APEJ Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
FIG. 100 APEJ Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
FIG. 101 APEJ Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
FIG. 102 MEA Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
FIG. 103 MEA Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
FIG. 104 MEA Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
FIG. 105 MEA Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
FIG. 106 MEA Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
FIG. 107 MEA Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
FIG. 108 MEA Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
FIG. 109 MEA Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
FIG. 110 MEA Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
FIG. 111 MEA Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the expected forecast CAGR for Drug Discovery Services from 2022-2032?
From 2022-2032, Drug Discovery Services demand is likely to surge at a 10.1% CAGR
At what value will the market for Drug Discovery Services close in 2032?
By 2032, the market for Drug Discovery Services is likely to be valued at US$ 50 Billion
What is the expected market value for the U.S Drug Discovery Services market?
By 2032, Fact.MR expects the U.S market for Drug Discovery Services to reach US$ 20 Billion
How opportunistic is the Chinese market for Drug Discovery Services market?
China is expected to register a 9.7% CAGR with regard to the Drug Discovery Services industry
What is the expected growth rate for the Japanese market?
Japan is expected to document a CAGR worth 8.5% in the Drug Discovery Services market
Which type will account for the maximum Drug Discovery Services revenue?
Medicinal Chemistry will expand the fastest during the forecast period.
What is the expected worth of the Drug Discovery Services industry in 2022?
By 2022, Fact.MR expected demand for Drug Discovery Services to reach US$ 19 Billion
What was the market worth for Drug Discovery Services in 2021?
As of 2021, Fact.MR estimated the Drug Discovery Services market to have reached US$ 17 Billion
At what CAGR did the Drug Discovery Services market flourish from 2015-2021?
From 2015-2021, the Drug Discovery Services market grew at an 8% value CAGR
Drug Discovery Services Market